Impact of race on survival in men with metastatic hormone-refractory prostate cancer

Urology

Volumn 64, Issue 2, 2004, Pages 212-217

  Halabi, Susan ^a,b   Small, Eric J ^d   Vogelzang, Nicholas J ^c   Barrier Jr , Robert C ^b   George, Stephen L ^a,b   Gilligan, Timothy D ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Cancer and Leukemia Group B Statistical Center   (United States)

^c NEVADA CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; HEMOGLOBIN; LACTATE DEHYDROGENASE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CANCER THERAPY; CASTRATION; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION; MALE; METASTASIS; MULTIVARIATE ANALYSIS; NEGRO; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; STATISTICAL ANALYSIS; TESTOSTERONE BLOOD LEVEL;

ADENOCARCINOMA; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; CONTINENTAL POPULATION GROUPS; DRUG RESISTANCE, NEOPLASM; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; NEOPLASM METASTASIS; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SALVAGE THERAPY; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 4143086197     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.04.014     Document Type: Article

References (15)

1. Polednak A.P., Flannery J.T. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer. 70:1992;2152-2158
2. Powell I.J. The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer a multivariate analysis of positive surgical margins. Urology. 49:1997;726-731
3. Pienta K.J., Demers R., Hoff M., et al. Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area, 1973 to 1987. Urology. 45:1995;93-102
4. Moul J.W., Douglas T.H., McCarthy W.F., et al. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol. 155:1996;1667-1673
5. Farkas A., Marcella S., Rhoads G.G. Ethnic and racial differences in prostate cancer incidence and mortality. Ethn Dis. 10:2000;69-75
6. Brawley O.W., Knopf K., Merrill R. The epidemiology of prostate cancer part I descriptive epidemiology. Semin Urol Oncol. 16:1998;187-192
7. Robbins A.S., Whittemore A.S., Van Den Eeden S.K. Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst. 90:1998;986-990
8. Roach M. III, Forte D., Alexander M. Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst. 91:1999;801-803
9. Powell I.J., Banerjee M., Novallo M., et al. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology. 55:2000;246-251
10. Optenberg S.A., Thompson I.M., Friedrichs P., et al. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 274:1995;1599-1605
11. Freedland S.J., Jalkut M., Dorey F., et al. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology. 56:2000;87-91
12. Powell I.J., Schwartz K., Hussain M. Removal of the financial barrier to health care does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology. 46:1995;825-830
13. Halabi S., Small E.J., Kantoff P.W., et al. A prognostic model for predicting overall survival in men with advanced prostate cancer. J Clin Oncol. 21:2003;1232-1237
14. Merrill R.M., Lyon J.L. Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology. 55:2000;730-735
15. Thompson I.M., Tangen C.M., Tolcher A., et al. Association of African-American ethnic background with survival in men with metastatic prostate cancer. J Natl Cancer Inst. 93:2001;219-225